Spotlight on Stem Cells

Elaine Fuchs and Craig Venter touted the promise of stem cell research at the American Society for Cell Biology annual meeting.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Elaine Fuchs, Craig VenterROCKEFELLER UNIVERSITY/J. CRAIG VENTER INSTITUTEDiscussing her work to decipher the transition from stem cell quiescence to activation at the American Society for Cell Biology (ASCB) annual meeting this week, Rockefeller University’s Elaine Fuchs said that for as much as researchers know about these progenitor cells, there is much left to learn. “There is a lot of exciting science left to do in the stem cell field,” Fuchs said during her keynote talk on the biology of stem cells, in which she spoke about her group’s work investigating cancer stem cells and the niche-specific signals that instruct stem cells to divide at certain times, like during periods of hair growth.

Craig Venter took the stage immediately after Fuchs. “I learned tonight that I am not bald, I just have quiescent stem cells,” he joked. In his talk, Venter noted that advances in single-cell sequencing technology and synthetic genomics have been a boon for stem cell research, allowing researchers to pinpoint the genetics of stemness. He and his colleagues are now “developing methods to rewrite the genetic code of stem cells,” he said.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide